Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supha Pharmachem Ltd has postponed its Board Meeting originally scheduled for February 14, 2026, to February 25, 2026. The delay is due to non-availability of financial information from its overseas subsidiary in Singapore, which is needed to finalize the consolidated financial results. The rescheduled meeting will consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The trading window for insiders remains closed from January 1, 2026, and will reopen 48 hours after the results are declared.
The delay itself is not unusual for companies with overseas subsidiaries needing to consolidate financials, but it signals some operational or reporting challenges at the Singapore subsidiary. Shareholders should watch for the actual Q3 numbers on February 25, 2026 to assess the subsidiary's contribution and overall financial health.